ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · Real-Time Price · USD

5.53

-0.05 (-0.90%)

At close: Apr 1, 2025, 4:00 PM

5.47

-0.06 (-1.14%)

After-hours: Apr 1, 2025, 6:00 PM EDT

ORIC Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2017
Net Income	-127.85	-100.7	-89.12	-78.72	-73.7	Upgrade
Depreciation & Amortization	1.11	1.03	0.97	0.9	0.97	Upgrade
Loss (Gain) From Sale of Assets	-	0.02	0.04	0	-	Upgrade
Asset Writedown & Restructuring Costs	-	-	-	-	19.84	Upgrade
Loss (Gain) From Sale of Investments	-8.1	-6.17	-1.04	1.35	0.3	Upgrade
Stock-Based Compensation	20.21	15.23	14.46	12.85	5.28	Upgrade
Change in Accounts Payable	1.83	3.28	-1.48	2.93	4.3	Upgrade
Change in Other Net Operating Assets	0.14	1.62	1.03	1.14	-2.26	Upgrade
Operating Cash Flow	-112.66	-85.69	-75.14	-59.54	-45.27	Upgrade
Capital Expenditures	-1.19	-0.85	-2.08	-0.94	-0.67	Upgrade
Investment in Securities	23.33	-42.55	-107.17	159.37	-215.49	Upgrade
Other Investing Activities	-	-	-	-	0.19	Upgrade
Investing Cash Flow	22.14	-43.4	-109.25	158.44	-215.96	Upgrade
Issuance of Common Stock	126.72	85.89	25.62	50.99	271.75	Upgrade
Other Financing Activities	-0.17	-0.23	-0.4	-1.85	-21.24	Upgrade
Financing Cash Flow	126.55	85.66	25.23	49.13	250.51	Upgrade
Net Cash Flow	36.02	-43.43	-159.17	148.03	-10.71	Upgrade
Free Cash Flow	-113.85	-86.54	-77.22	-60.48	-45.94	Upgrade
Free Cash Flow Per Share	-1.63	-1.68	-1.95	-1.59	-2.09	Upgrade
Levered Free Cash Flow	-67.1	-49.08	-42.02	-32.71	-23.87	Upgrade
Unlevered Free Cash Flow	-67.1	-49.08	-42.02	-32.71	-23.87	Upgrade
Change in Net Working Capital	-2.08	-4.75	1.14	-3.78	-1.39	Upgrade

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q